A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Clinical trial NCT07200908 · RECRUITING

Trial details

NCT number: NCT07200908
Sponsor: Mirum Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis D Infection

Start date: 2025-08-27
Primary completion: 2027-06-30
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.